Clinical Trial Update: A Single-Dose Study to Investigate the Pharmacokinetics of MK-7655 in Participants With Impaired Renal Function (MK-7655-005) [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics study evaluating MK-7655 in participants with impaired renal function has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infectious Disease

Drugs mentioned

• MK-7655

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Infectious Disease | Phase 1 | Status: COMPLETED | Results posted: 2019-07-19